Vitamin D supplementation during TB treatment improves patient symptoms, but does not accelerate the clearance of TB bacteria.
SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage lung cancer diagnostics, announced today the acceptance of its patent application ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback